Hugin Group Company Profile

12:37 EDT 24th June 2018 | BioPortfolio

Hugin offers communication professionals the most innovative, straight through processing solution for delivery of unedited corporate news to targeted audiences. Hugin's breakthrough technology has transformed this process for hundreds of Europe's leading companies. “Using Hugin’s international press services has proven to be a highly valuable tool for gaining press to our markets outside of Scandinavia. We have accessed numerous channels that we couldn’t have tapped on our own.”


Larsbjørnsstræde 3
Copenhagen K


Phone: 45 70 27 15 44
Fax: 45 33 37 72 13
Email: bo.dungal@hugingroup

News Articles [406 Associated News Articles listed on BioPortfolio]

Hugin to Retire from Celgene Board, CEO Alles Adds Chairman Role

Bob Hugin, chairman of Celgene’s (NASDAQ: CELG) board of directors, plans to retire effective Feb. 5. Mark Alles, CEO of the Summit, NJ, drugmaker, will take on the additional role of chairman after...

BRIEF—Bob Hugin steps down from Celgene board of directors

Long-time Celgene executive chairman Bob Hugin has retired, the firm has announced. Chief executive Mark…

Former pharma exec, Christie backer seeks to oust Menendez

In this Jan. 31, 2017, file photo, President Donald Trump listens during a meeting with pharmaceutical executives including Celgene Corp.'s Executive Chairman Bob Hugin, second from right, in the ...

Celgene Executive Chairman Hugin to retire

Former Celgene CEO Hugin expected to announce run for Senate

It's Confirmed: Celgene's Former CEO and Chairman is Making a Run for the Senate

Bob Hugin announced his campaign on Monday in an email.

Celgene’s CEO Mark Alles is appointed as chairman

He succeeds Bob Hugin who is retiring from the pharma firm

Celgene Executive Chairman Bob Hugin to retire

Fresh from its acquisition of Juno Therapeutics, Celgene has announced that its Executive Chairman Bob Hurgin is to retire effective 5 February, while Chief Executive Officer Mark Alles will step up t...

PubMed Articles [1797 Associated PubMed Articles listed on BioPortfolio]

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Nephroprotective Effect of Zingerone against CCl-Induced Renal Toxicity in Swiss Albino Mice: Molecular Mechanism.

The protective effects of Zingerone against CCl induced nephrotoxicity in Swiss albino mice via modulation of metabolizing enzyme, oxidative stress, inflammatory cytokines, and apoptosis. The biochemi...

Clinical Trials [3703 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

the Influence of Sleep Improvement Through Different Methods on Patients in ICU

In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and t...

Companies [1617 Associated Companies listed on BioPortfolio]

Hugin Group

Hugin offers communication professionals the most innovative, straight through processing solution for delivery of unedited corporate news to targeted audiences. Hugin's breakthrough technology has tr...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

Man Group plc

The Man Group has its origins over 200 years ago in a broking business founded by James Man and was floated on the London Stock Exchange in 1994. Man Group plc trades on the London Stock Exchange (EMG...

More Information about "Hugin Group" on BioPortfolio

We have published hundreds of Hugin Group news stories on BioPortfolio along with dozens of Hugin Group Clinical Trials and PubMed Articles about Hugin Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hugin Group Companies in our database. You can also find out about relevant Hugin Group Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record